• Published 28 Nov 2025

Advances in Small Molecule Drug Development, Boston 2026

  • Events

Join us on February 11th 2026 at the Cambridge Innovation Centre, Cambridge, for a one-day meeting focused on the latest advances in small molecule drug development, exploring the discovery, synthesis, and delivery of novel small molecule therapeutics and conjugates.

The event encourages open discussion between academia, biotech, and pharma to share knowledge and strengthen collaboration across the development pipeline.

Key topics include:

  • Novel chemistry-enabled modalities and conjugates
  • Scalable synthesis and process development
  • Digital, data, and automation in chemical design
  • Analytical science and in-process control
  • Future trends in small molecule R&D

Featured Speakers

Plenary speaker:

Additional speakers:

  • Yexenia E. Nieves Quinones, Principal Scientist – Process Chemistry, Pfizer
  • Karli Holman, Principal Scientist – Lead Discovery Chemistry, GSK
  • Philippe Bolduc, Senior Scientist – Synthetic Medicine Design, Biogen
  • John Traverse, Executive Director – Process Chemistry, Kymera Therapeutics
  • Sami Svanbäck, CEO, The Solubility Company
  • Rob Crook, Director of Chemical Science, CatSci

Badge Registration Form

Registration for this event is now closed.

Who Should Attend

This conference is for scientists, researchers, and industry professionals involved in the discovery, development, and manufacture of small molecules and conjugates. It offers an opportunity to share experiences, learn from peers, and build connections across different parts of the development journey.

Who should attend:

  • Senior leaders in biotech and pharma
  • Discovery and process chemists
  • Analytical scientists and formulation specialists
  • Digital, data, and automation experts
  • Academic group leaders and research directors

Join us to explore how science, technology, and interdisciplinary collaboration are reshaping the future of drug development.

Date, Location and Venue

February 11th 2026, 09:30 – 17:00

Mosaic, Cambridge Innovation Center (CIC)

3rd Floor, 245 Main Street

Cambridge, MA 02142

United States

Travel and Parking

We recommend using public transit or a ride-share service to reach Kendall Square where the 245 Main St building is located. The closest public transit station is Kendall on the Red Line. There is a parking garage in the nearby One Broadway building, which can be accessed via Third Street. A map of all recommended parking garages can be found here.

Sponsors and Partners

Please contact Dan Croucher (dan.croucher@catsci.com) for sponsorship information.

Organising Committee

Dan Croucher: dan.croucher@catsci.com

Carlos Cote: carlos.cote@catsci.com

Stay informed on LinkedIn

Resources & Insights

  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders
  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders